Literature DB >> 18794297

The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation.

Jerzy Fraczek1, Tae Whan Kim, Hui Xiao, Jianhong Yao, Qian Wen, Yali Li, Jean-Laurent Casanova, Juliusz Pryjma, Xiaoxia Li.   

Abstract

Two parallel interleukin-1 (IL-1)-mediated signaling pathways have been uncovered for IL-1R-TLR-mediated NFkappaB activation: TAK1-dependent and MEKK3-dependent pathways, respectively. The TAK1-dependent pathway leads to IKKalpha/beta phosphorylation and IKKbeta activation, resulting in classic NFkappaB activation through IkappaBalpha phosphorylation and degradation. The TAK1-independent MEKK3-dependent pathway involves IKKgamma phosphorylation and IKKalpha activation, resulting in NFkappaB activation through dissociation of phosphorylated IkappaBalpha from NFkappaB without IkappaBalpha degradation. IL-1 receptor-associated kinase 4 (IRAK4) belongs to the IRAK family of proteins and plays a critical role in IL-1R/TLR-mediated signaling. IRAK4 kinase-inactive mutant failed to mediate the IL-1R-TLR-induced TAK1-dependent NFkappaB activation pathway, but mediated IL-1-induced TAK1-independent NFkappaB activation and retained the ability to activate substantial gene expression, indicating a structural role of IRAK4 in mediating this alternative NFkappaB activation pathway. Deletion analysis of IRAK4 indicates the essential structural role of the IRAK4 death domain in receptor proximal signaling for mediating IL-1R-TLR-induced NFkappaB activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794297      PMCID: PMC2581573          DOI: 10.1074/jbc.M804779200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

2.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.

Authors:  T H Chuang; R J Ulevitch
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

4.  Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.

Authors:  Zhengfan Jiang; Jun Ninomiya-Tsuji; Youcun Qian; Kunihiro Matsumoto; Xiaoxia Li
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  IRAK4 in TLR/IL-1R signaling: possible clinical applications.

Authors:  Xiaoxia Li
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

6.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.

Authors:  Nobutaka Suzuki; Shinobu Suzuki; Gordon S Duncan; Douglas G Millar; Teiji Wada; Christine Mirtsos; Hidetoshi Takada; Andrew Wakeham; Annick Itie; Shyun Li; Josef M Penninger; Holger Wesche; Pamela S Ohashi; Tak W Mak; Wen-Chen Yeh
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

7.  TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Satoshi Uematsu; Katsuaki Hoshino; Tsuneyasu Kaisho; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

8.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

9.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

10.  Pyogenic bacterial infections in humans with IRAK-4 deficiency.

Authors:  Capucine Picard; Anne Puel; Marion Bonnet; Cheng-Lung Ku; Jacinta Bustamante; Kun Yang; Claire Soudais; Stéphanie Dupuis; Jacqueline Feinberg; Claire Fieschi; Carole Elbim; Remi Hitchcock; David Lammas; Graham Davies; Abdulaziz Al-Ghonaium; Hassan Al-Rayes; Sulaiman Al-Jumaah; Sami Al-Hajjar; Ibrahim Zaid Al-Mohsen; Husn H Frayha; Rajivi Rucker; Thomas R Hawn; Alan Aderem; Haysam Tufenkeji; Soichi Haraguchi; Noorbibi K Day; Robert A Good; Marie-Anne Gougerot-Pocidalo; Adrian Ozinsky; Jean-Laurent Casanova
Journal:  Science       Date:  2003-03-13       Impact factor: 47.728

View more
  22 in total

1.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

2.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

3.  Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.

Authors:  Leah Cushing; Wayne Stochaj; Marshall Siegel; Robert Czerwinski; Ken Dower; Quentin Wright; Margaret Hirschfield; Jean-Laurent Casanova; Capucine Picard; Anne Puel; Lih-Ling Lin; Vikram R Rao
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

4.  IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.

Authors:  Hao Zhou; Minjia Yu; Koichi Fukuda; Jinteak Im; Peng Yao; Wei Cui; Katarzyna Bulek; Jarod Zepp; Youzhong Wan; Tae Whan Kim; Weiguo Yin; Victoria Ma; James Thomas; Jun Gu; Jian-an Wang; Paul E DiCorleto; Paul L Fox; Jun Qin; Xiaoxia Li
Journal:  EMBO J       Date:  2013-02-01       Impact factor: 11.598

5.  Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity.

Authors:  Shailesh Dudhgaonkar; Sourabh Ranade; Jignesh Nagar; Siva Subramani; Durga Shiv Prasad; Preethi Karunanithi; Ratika Srivastava; Kamala Venkatesh; Sabariya Selvam; Prasad Krishnamurthy; T Thanga Mariappan; Ajay Saxena; Li Fan; Dawn K Stetsko; Deborah A Holloway; Xin Li; Jun Zhu; Wen-Pin Yang; Stefan Ruepp; Satheesh Nair; Joseph Santella; John Duncia; John Hynes; Kim W McIntyre; Julie A Carman
Journal:  J Immunol       Date:  2016-12-21       Impact factor: 5.422

6.  Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.

Authors:  Daoxiang Zhang; Lin Li; Hongmei Jiang; Brett L Knolhoff; Albert C Lockhart; Andrea Wang-Gillam; David G DeNardo; Marianna B Ruzinova; Kian-Huat Lim
Journal:  Clin Cancer Res       Date:  2016-10-04       Impact factor: 12.531

7.  IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.

Authors:  Leah Cushing; Aaron Winkler; Scott A Jelinsky; Katherine Lee; Wouter Korver; Rachael Hawtin; Vikram R Rao; Margaret Fleming; Lih-Ling Lin
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

Review 8.  The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent.

Authors:  Bin Bao; Archana Thakur; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Shadan Ali; Lawrence G Lum; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2011-11-29

9.  IRAKM-Mincle axis links cell death to inflammation: Pathophysiological implications for chronic alcoholic liver disease.

Authors:  Hao Zhou; Minjia Yu; Junjie Zhao; Bradley N Martin; Sanjoy Roychowdhury; Megan R McMullen; Emily Wang; Paul L Fox; Sho Yamasaki; Laura E Nagy; Xiaoxia Li
Journal:  Hepatology       Date:  2016-10-25       Impact factor: 17.425

10.  Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice.

Authors:  Meghan E Pennini; Darren J Perkins; Andres M Salazar; Michael Lipsky; Stefanie N Vogel
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.